Medical student Claudia Chan Shu-ying is currently developing an AI-driven platform titled CancerCompanion, designed to assist cancer patients in Hong Kong. The initiative stems from research indicating that emotional distress, such as anxiety and depression, can negatively impact survival rates for those undergoing cancer treatment.

According to the reporting, the tool is intended to function as a digital companion that offers support outside of standard clinical hours. This is particularly aimed at addressing the needs of patients who may experience distress late at night or during periods when professional medical staff are unavailable. The system utilizes artificial intelligence to provide this ongoing emotional assistance, bridging the gap between scheduled hospital visits. While the report highlights the potential benefits of the technology, it focuses primarily on the development phase of the project and the underlying clinical research regarding the link between mental health and physical outcomes in cancer patients.